Results 201 to 210 of about 61,617 (230)
Some of the next articles are maybe not open access.

Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists

Glia, 2019
Neuroprotective M2‐skewed microglia appear as promising to alter the course of neurodegenerative diseases and G protein‐coupled receptors (GPCRs) are potential targets to achieve such microglial polarization.
R. Franco   +13 more
semanticscholar   +1 more source

Development of Adenosine A2A Receptor Antagonists for the Treatment of Parkinson's Disease: A Recent Update and Challenge.

ACS Chemical Neuroscience, 2018
Parkinson's disease (PD) is a neurodegenerative disease with significant unmet medical needs. The current dopamine-centered treatments aim to restore motor functions of patients without slowing the disease progression.
Jiyue Zheng, Xiaohu Zhang, Xuechu Zhen
semanticscholar   +1 more source

Adenosine A2A receptor and glia.

International review of neurobiology, 2023
Zhihua Gao
semanticscholar   +1 more source

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung   +2 more
exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen   +2 more
exaly  

Potential therapeutic effects of antagonizing adenosine A2A receptor, curcumin and niacin in rotenone-induced Parkinson’s disease mice model

Molecular and Cellular Biochemistry, 2019
T. Motawi   +5 more
semanticscholar   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Home - About - Disclaimer - Privacy